Beijing Tiantan Biological Products Corp Ltd (600161) — Financial Flexibility Index
Beijing Tiantan Biological Products Corp Ltd (600161) has a Financial Flexibility Index of 0.28x as of September 2025. Free cash flow of CN¥443.87 Million (operating CF CN¥318.80 Million minus capex CN¥125.07 Million) represents 0% of total liabilities (CN¥1.60 Billion). Also explore net asset growth rate of Beijing Tiantan Biological Products Corp to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Tiantan Biological Products Corp Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Check asset allocation strategy of Beijing Tiantan Biological Products Corp to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Beijing Tiantan Biological Products Corp Ltd. For the full company profile including market capitalisation, see 600161 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | CN¥1.89 Billion | CN¥819.78 Million | CN¥1.34 Billion | ▼ -41.7% |
| 2023 | 2.42x | CN¥3.47 Billion | CN¥2.39 Billion | CN¥1.43 Billion | ▲ +54.7% |
| 2022 | 1.57x | CN¥2.48 Billion | CN¥1.13 Billion | CN¥1.58 Billion | ▼ -2.9% |
| 2021 | 1.61x | CN¥2.11 Billion | CN¥980.35 Million | CN¥1.31 Billion | ▲ +85.6% |
| 2020 | 0.87x | CN¥1.31 Billion | CN¥702.11 Million | CN¥1.51 Billion | ▼ -15.5% |
| 2019 | 1.03x | CN¥1.17 Billion | CN¥642.47 Million | CN¥1.14 Billion | ▼ -23.8% |
| 2018 | 1.35x | CN¥971.82 Million | CN¥677.92 Million | CN¥720.19 Million | ▲ +78.8% |
| 2017 | 0.75x | CN¥363.26 Million | CN¥218.39 Million | CN¥481.46 Million | ▲ +295.4% |
| 2016 | 0.19x | CN¥637.77 Million | CN¥428.37 Million | CN¥3.34 Billion | ▼ -16.3% |
| 2015 | 0.23x | CN¥773.83 Million | CN¥473.26 Million | CN¥3.40 Billion | ▼ -8.1% |
| 2014 | 0.25x | CN¥942.11 Million | CN¥477.95 Million | CN¥3.80 Billion | ▼ -23.0% |
| 2013 | 0.32x | CN¥1.11 Billion | CN¥566.43 Million | CN¥3.46 Billion | ▼ -1.4% |
| 2012 | 0.33x | CN¥989.88 Million | CN¥432.00 Million | CN¥3.03 Billion | ▼ -45.8% |
| 2011 | 0.60x | CN¥1.07 Billion | CN¥353.15 Million | CN¥1.78 Billion | ▲ +63.2% |
| 2010 | 0.37x | CN¥482.39 Million | CN¥184.85 Million | CN¥1.31 Billion | ▼ -30.0% |
| 2009 | 0.53x | CN¥639.39 Million | CN¥448.23 Million | CN¥1.21 Billion | ▼ -45.7% |
| 2008 | 0.97x | CN¥426.70 Million | CN¥276.39 Million | CN¥439.35 Million | ▲ +63.1% |
| 2007 | 0.60x | CN¥219.95 Million | CN¥153.55 Million | CN¥369.34 Million | ▼ -6.1% |
| 2006 | 0.63x | CN¥225.86 Million | CN¥154.36 Million | CN¥356.20 Million | ▼ -33.6% |
| 2005 | 0.95x | CN¥171.47 Million | CN¥131.69 Million | CN¥179.67 Million | ▼ -38.8% |
| 2004 | 1.56x | CN¥196.00 Million | CN¥110.11 Million | CN¥125.70 Million | ▲ +62.3% |
| 2003 | 0.96x | CN¥152.95 Million | CN¥62.93 Million | CN¥159.24 Million | ▲ +73.8% |
| 2002 | 0.55x | CN¥119.21 Million | CN¥84.38 Million | CN¥215.73 Million | ▲ +0.4% |
| 2001 | 0.55x | CN¥95.58 Million | CN¥46.49 Million | CN¥173.64 Million | ▼ -0.2% |
| 2000 | 0.55x | CN¥91.94 Million | CN¥47.90 Million | CN¥166.77 Million | ▲ +2.6% |
| 1999 | 0.54x | CN¥85.92 Million | CN¥42.58 Million | CN¥159.88 Million | ▼ -25.6% |
| 1998 | 0.72x | CN¥81.32 Million | CN¥23.71 Million | CN¥112.54 Million | — |